Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European countryFamily doctors' involvement with families in EstoniaThe European primary care monitor: structure, process and outcome indicators.Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia.Family doctors' knowledge and self-reported care of type 2 diabetes patients in comparison to the clinical practice guideline: cross-sectional study.The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.Lactase non-persistence and milk consumption in EstoniaComparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.Metabolic syndrome in estonia: prevalence and associations with insulin resistance.The strength of primary care in Europe: an international comparative study.Predictors of quality of life of patients with type 2 diabetes.Impact of a new sarco-osteopenia definition on health-related quality of life in a population-based cohort in Northern Europe.Bone mineral density reference range in Estonia: a comparison with the standard database (NHANES III).Accessibility and use of health services among older Estonian population.Adverse lifestyle and health-related quality of life: gender differences in patients with and without chronic conditions.The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity.Insulin Resistance in Early Rheumatoid Arthritis Is Associated with Low Appendicular Lean MassErratum to: The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study.Primary care in Baltic countries: a comparison of progress and present systems.Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia.How to define a common path in internal medicine in the European diverse health care systems?Assessment of lactose tests.Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome.Level of knowledge and sources of information about the rheumatoid arthritis in Estonian patients.Patient evaluation on family doctors' family orientation.Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.Impact of molecularly defined hypolactasia, self-perceived milk intolerance and milk consumption on bone mineral density in a population sample in Northern Europe.The sources of disease-related information for Estonia's rheumatoid arthritis patients: a qualitative study.Use of general practice and rheumatology outpatient services in rheumatoid arthritis.Assistive devices, home adjustments and external help in rheumatoid arthritis.The impact of comorbidities on hip fracture mortality: a retrospective population-based cohort study.Compliance with treatment of rheumatoid arthritis.Hypolactasia: a common enzyme deficiency leading to lactose malabsorption and intolerance.Satisfaction with access to health services: the perspective of Estonian patients with rheumatoid arthritis.Primary health care in transition: Variations in service profiles of general practitioners in Estonia and in Finland between 1993 and 2012Primary health care in Estonia
P50
Q21257203-572AB21E-6777-4D3B-9AAD-F819E2493129Q24793396-13963427-AD3A-477E-8AC9-402B64F6968DQ30497301-ECA910E3-D23D-4670-8F41-0DE02BC50A3CQ31138460-56B70B51-A98A-4ABC-991B-18603F24AE65Q33246858-B9C11F75-8899-47D6-9E4B-25D691281777Q33768328-1A625269-C988-418E-8C49-6944C5F169C3Q33866496-A598067F-E97F-4D34-AFF1-F3A477DE761AQ33982437-E139B898-172D-44B4-B99D-4447B6CE54E2Q35810417-5D32628F-3607-4164-82AF-A0A8CBE5F07AQ37258374-FF2DF5BA-4D66-4B17-8504-B371C31F0048Q37405492-1D211DE1-9830-41E6-9DEE-D853EC9B6C71Q38468800-84C8FC0E-38C3-4580-AE32-40A318D4B3DDQ38491400-4D5E3F91-02C4-4CDC-B5B0-52F4022E94FEQ39896047-A9475BAC-6746-46D4-88A5-1DCBE7BAE048Q40339293-57EF5457-742A-4108-B4D3-671820BE8BC6Q40797292-C17965D6-1CEE-4E7F-AD34-969CC4C03FDAQ41432967-3E4A3F73-8919-45A1-837A-C4DE4E0D224EQ42350158-50320C2F-6334-4F7F-80D8-F19905A4CAC4Q42667230-CD64BCE3-29F2-42A6-BF1D-FE70F8F9F86FQ43080295-26A7CCDE-BF38-4825-804C-1496F69D1E60Q43900543-EE7D25C0-6A4F-4974-9082-711E8465D0DBQ44266291-59B6C15C-A21D-4E71-9BC5-51BB224DDE23Q44739624-A830666E-9686-42BF-9244-93475CE03DCEQ44837050-38CFBE47-5CBA-460C-B942-3A74E4AEECF1Q45275263-5CA24FE8-02A7-4184-881F-2874B8A8CC4EQ46217023-F3888C72-7397-42E4-91DE-AC6DC630C631Q46224643-A39A8309-C814-4309-A73D-3D72657B657CQ46626294-FEF3C987-95F7-460E-9794-A4FA85FE39D1Q48537075-02CB8B4D-31DD-4ABB-A35B-6552BEAED6B1Q48562734-189E8036-3FF7-45C7-8748-23E4DE749AC0Q50493965-937B5A59-78C1-4013-BEE5-D786158407D0Q50608134-1714DEB6-8DC6-4200-8D3F-EF9127A34C32Q55056899-8694C29B-A571-4598-A8E2-D8F0F27E1070Q55209197-8C4EA80E-3BC6-4936-92A9-7EA3B8939E3FQ57480101-F7F40BB9-4EF9-4869-9DB3-B690EAA8EB85Q60390453-7DBF5170-CC26-431B-A48A-161F6440DF45
P50
description
Forscher
@de
chercheur
@fr
hulumtues
@sq
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Margus Lember
@ast
Margus Lember
@en
Margus Lember
@es
Margus Lember
@et
Margus Lember
@nl
type
label
Margus Lember
@ast
Margus Lember
@en
Margus Lember
@es
Margus Lember
@et
Margus Lember
@nl
prefLabel
Margus Lember
@ast
Margus Lember
@en
Margus Lember
@es
Margus Lember
@et
Margus Lember
@nl
P21
P213
0000 0003 8456 5641
P214
344144647682323556992
P2953
Margus_Lember
P31
P496
0000-0003-0746-5954
P569
1960-12-12T00:00:00Z
P7859
viaf-344144647682323556992